Protease Inhibitor class drugs
13 results
Atazanavir (atazanavir)
(ATAZANAVIR)Zydus Lifesciences Limited
Darunavir (darunavir)
(Darunavir)Amneal Pharmaceuticals NY LLC
Usage: Darunavir, when combined with ritonavir and other antiretroviral agents, is indicated for the treatment of HIV-1 infection in patients aged 3 years and older.
Darunavir (darunavir)
(Darunavir)Zydus Lifesciences Limited
Evotaz (atazanavir and cobicistat)
(atazanavir and cobicistat)E.R. Squibb & Sons, L.L.C.
Usage: EVOTAZ® is indicated for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 35 kg, used in combination with other antiretroviral agents. Treatment in experienced patients should consider baseline protease inhibitor resistance.
Lopinavir and ritonavir (lopinavir and ritonavir)
(Lopinavir and Ritonavir)Laurus Labs Limited
Usage: Lopinavir and ritonavir are indicated for the treatment of HIV-1 infection in adults and pediatric patients aged 14 days and older, used in combination with other antiretroviral agents. Treatment should be guided by genotypic or phenotypic testing and treatment history.
Norvir (ritonavir)
(Ritonavir)AbbVie Inc.
Usage: NORVIR is indicated for the treatment of HIV-1 infection in combination with other antiretroviral agents, applicable for both adults (tablets) and pediatric patients (oral powder).
Paxlovid (nirmatrelvir and ritonavir)
(nirmatrelvir and ritonavir)Pfizer Laboratories Div Pfizer Inc
Usage: PAXLOVID is indicated for treating mild-to-moderate COVID-19 in adults at high risk for severe disease progression, including hospitalization or death. It is not approved for pre-exposure or post-exposure prophylaxis against COVID-19.
Prezcobix (darunavir ethanolate and cobicistat)
(DARUNAVIR ETHANOLATE and COBICISTAT)Janssen Products LP
Usage: PREZCOBIX is indicated for the treatment of HIV-1 in combination with other antiretroviral agents for both treatment-naïve and treatment-experienced adults and pediatric patients weighing at least 25 kg, provided there are no darunavir resistance-associated substitutions.
Prezcobix (darunavir ethanolate and cobicistat)
(DARUNAVIR ETHANOLATE and COBICISTAT)A-S Medication Solutions
Usage: PREZCOBIX is indicated for the treatment of HIV-1 infection in adults and pediatric patients (≥40 kg), both treatment-naïve and treatment-experienced, when used with other antiretroviral agents and in patients without certain darunavir resistance-associated substitutions.
Prezista (darunavir)
(darunavir)Janssen Products LP
Usage: PREZISTA, in combination with ritonavir and other antiretroviral agents, is indicated for treating HIV-1 infection in adults and pediatric patients aged 3 and older.